Company intelligence / Profile preview
Troikaa Pharmaceuticals
Ahmedabad, Gujarat, Indiatroikaa.com ↗
- Ownership
- Private
- Employees
- ~3500
- Development stage
- Other
01
Overview
Troikaa has a strong commercial presence with patented and proprietary drug delivery technologies. Its lead brands like Dynapar AQ/Dynapar QPS have significant market share in pain management. The company has launched the world’s first intranasal methylcobalamin spray for vitamin B12 deficiency using its patented Nasomax technology. Three more products were reported to be at the clinical trial stage as of early/mid–2020s.
- Therapeutic areas
- HematologyGastroenterologyNeurologyOther
- Modalities
- Small moleculeBiologicNovel Drug Delivery Systems (NDDS)
- Industry
- Biotech
02
Drug pipeline
2 assets1 more asset in the full pipeline.
03
Partnerships
BRD Medilabs
Beyond the preview
Go deeper on Troikaa Pharmaceuticals.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Troikaa Pharmaceuticals.